DZ2756A1 - Composés azabicycliques substitués nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant. - Google Patents

Composés azabicycliques substitués nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.

Info

Publication number: DZ2756A1
Authority: DZ; Algeria
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; new process; azabicyclic compounds
Prior art date: 1998-04-09

Application number

DZ990057A

Other languages

English (en)

Inventor

Joel Michael Hawkins

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-09

Filing date

1999-04-07

Publication date

2003-09-15

1999-04-07 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2003-09-15 Application granted granted Critical

2003-09-15 Publication of DZ2756A1 publication Critical patent/DZ2756A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Addiction (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Obesity (AREA)
Gynecology & Obstetrics (AREA)
Child & Adolescent Psychology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Luminescent Compositions (AREA)

DZ990057A 1998-04-09 1999-04-07 Composés azabicycliques substitués nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant. DZ2756A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US8123798P	1998-04-09	1998-04-09

Publications (1)

Publication Number	Publication Date
DZ2756A1 true DZ2756A1 (fr)	2003-09-15

Family

ID=22162936

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ990057A DZ2756A1 (fr)	1998-04-09	1999-04-07	Composés azabicycliques substitués nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.

Country Status (40)

Country	Link
US (2)	US6525048B1 (fr)
EP (1)	EP1070065B1 (fr)
JP (1)	JP3496759B2 (fr)
KR (1)	KR100378931B1 (fr)
CN (1)	CN1117092C (fr)
AP (1)	AP1175A (fr)
AR (1)	AR015751A1 (fr)
AT (1)	ATE248838T1 (fr)
AU (1)	AU749254B2 (fr)
BG (1)	BG104915A (fr)
BR (1)	BR9909522A (fr)
CA (1)	CA2327782A1 (fr)
CO (1)	CO5080727A1 (fr)
CZ (1)	CZ20003684A3 (fr)
DE (1)	DE69910997T2 (fr)
DK (1)	DK1070065T3 (fr)
DZ (1)	DZ2756A1 (fr)
EA (1)	EA003400B1 (fr)
ES (1)	ES2204154T3 (fr)
HR (1)	HRP20000653A2 (fr)
HU (1)	HUP0102400A3 (fr)
ID (1)	ID26086A (fr)
IL (1)	IL138629A0 (fr)
IS (1)	IS5641A (fr)
MA (1)	MA26619A1 (fr)
MY (1)	MY133390A (fr)
NO (1)	NO20005004L (fr)
NZ (1)	NZ507010A (fr)
OA (1)	OA11496A (fr)
PA (1)	PA8469101A1 (fr)
PE (1)	PE20000413A1 (fr)
PL (1)	PL343408A1 (fr)
PT (1)	PT1070065E (fr)
SK (1)	SK14782000A3 (fr)
TN (1)	TNSN99056A1 (fr)
TR (1)	TR200002932T2 (fr)
TW (1)	TW555758B (fr)
WO (1)	WO1999052907A1 (fr)
YU (1)	YU59400A (fr)
ZA (1)	ZA992596B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6231833B1 (en)	1999-08-05	2001-05-15	Pfizer Inc	2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
UA62015C2 (en) *	1998-12-28	2003-12-15	Pfizer Prod Inc	Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
CZ299712B6 (cs)	1999-09-03	2008-10-29	Apbi Holdings, Llc	Použití dapoxetinu pro zvládnutí sexuální dysfunkce podáváním zpusobem podle potreby
GB2362826A (en) *	2000-06-02	2001-12-05	Lilly Co Eli	A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
WO2003065970A2 (fr) *	2001-02-20	2003-08-14	Royal College Of Surgeons Ie	Traitement de la fibromyalgie et du syndrome de fatigue associe au moyen d'antagonistes ou d'agonistes partiels de recepteurs 5ht1a
HRP20050798A2 (en) *	2003-03-12	2006-02-28	Pfizer Products Inc.	Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
BRPI0507250A (pt) *	2004-01-29	2007-06-26	Pfizer Prod Inc	combinações para tratar desordens do snc
JP4559749B2 (ja) *	2004-02-16	2010-10-13	あすか製薬株式会社	ピペラジニルピリジン誘導体
AR049478A1 (es)	2004-03-25	2006-08-09	Solvay Pharm Bv	Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
AR048112A1 (es) *	2004-03-25	2006-03-29	Solvay Pharm Bv	Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
CA2571555A1 (fr) *	2004-06-22	2006-01-05	Pfizer Products Inc.	Antagonistes des recepteurs d'histamine-3 diazabicycliques
EP2248524A3 (fr)	2004-08-25	2011-03-09	Takeda Pharmaceutical Company Limited	Agents preventifs/remedes pour l'incontinence de stress et procede de selecetion de ceux-ci
MX2007002842A (es) *	2004-09-10	2007-04-30	Pfizer Prod Inc	Metodos de tratamiento de trastornos cognitivos que usan derivados azabiciclicos de piridiloximetilo y benzoisoxazol.
RU2417082C2 (ru) *	2009-07-14	2011-04-27	Учреждение Российской Академии Наук Институт Физиологически Активных Веществ Ран (Ифав Ран)	Средство для восстановления утраченной памяти в норме и патологии у пациентов всех возрастных групп на основе n, n'-замещенных 3, 7-диазабицикло[3.3.1]нонанов, фармацевтическая композиция на его основе и способ ее применения
EP2919788A4 (fr)	2012-11-14	2016-05-25	Univ Johns Hopkins	Méthodes et compositions pour le traitement de la schizophrénie
WO2020087031A1 (fr)	2018-10-26	2020-04-30	The Research Foundation For The State University Of New York	Combinaison d'un inhibiteur de réabsorption spécifique de la sérotonine et d'un agoniste partiel du récepteur de la sérotonine 1a pour réduire la dyskinésie induite par l-dopa
WO2020183011A1 (fr)	2019-03-14	2020-09-17	Institut Curie	Inhibiteurs de htr1d et leurs utilisations dans le traitement du cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5106849A (en) *	1988-05-24	1992-04-21	American Home Products Corporation	Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders
WO1990008148A1 (fr) *	1989-01-23	1990-07-26	Pfizer Inc.	Agents anxiolytiques bis-aza-bicycliques
US5157034A (en) *	1991-02-27	1992-10-20	Pfizer Inc.	Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
AU655071B2 (en) *	1991-09-25	1994-12-01	Pfizer Inc.	Neuroleptic 2-substituted perhydro-1-H-pyrido(1,2a) pyrazines
US5262428A (en) *	1992-03-13	1993-11-16	Wake Forest University	Biologically active tropane derivatives
CA2138018C (fr) *	1992-06-16	1998-01-27	Frank J. Urban	Procede et intermediaires pour agents anxiolytiques bi-aza-bicycliques
GB9410512D0 (en) *	1994-05-25	1994-07-13	Smithkline Beecham Plc	Novel treatment
US5731307A (en) *	1994-09-30	1998-03-24	Pfizer, Inc.	Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
US5614523A (en) *	1995-01-17	1997-03-25	Eli Lilly And Company	Compounds having effects on serotonin-related systems

1999
- 1999-03-17 PA PA19998469101A patent/PA8469101A1/es unknown
- 1999-03-18 HR HR20000653A patent/HRP20000653A2/hr not_active Application Discontinuation
- 1999-03-18 YU YU59400A patent/YU59400A/sh unknown
- 1999-03-18 ES ES99945686T patent/ES2204154T3/es not_active Expired - Lifetime
- 1999-03-18 US US09/403,892 patent/US6525048B1/en not_active Expired - Fee Related
- 1999-03-18 EA EA200000910A patent/EA003400B1/ru not_active IP Right Cessation
- 1999-03-18 TR TR2000/02932T patent/TR200002932T2/xx unknown
- 1999-03-18 EP EP99945686A patent/EP1070065B1/fr not_active Expired - Lifetime
- 1999-03-18 SK SK1478-2000A patent/SK14782000A3/sk unknown
- 1999-03-18 BR BR9909522-0A patent/BR9909522A/pt not_active Application Discontinuation
- 1999-03-18 ID IDW20002017A patent/ID26086A/id unknown
- 1999-03-18 NZ NZ507010A patent/NZ507010A/en unknown
- 1999-03-18 PL PL99343408A patent/PL343408A1/xx not_active Application Discontinuation
- 1999-03-18 KR KR10-2000-7011167A patent/KR100378931B1/ko not_active Expired - Fee Related
- 1999-03-18 CN CN99807195A patent/CN1117092C/zh not_active Expired - Fee Related
- 1999-03-18 AU AU32687/99A patent/AU749254B2/en not_active Ceased
- 1999-03-18 DK DK99945686T patent/DK1070065T3/da active
- 1999-03-18 CZ CZ20003684A patent/CZ20003684A3/cs unknown
- 1999-03-18 JP JP2000543464A patent/JP3496759B2/ja not_active Expired - Fee Related
- 1999-03-18 HU HU0102400A patent/HUP0102400A3/hu unknown
- 1999-03-18 AT AT99945686T patent/ATE248838T1/de not_active IP Right Cessation
- 1999-03-18 IL IL13862999A patent/IL138629A0/xx unknown
- 1999-03-18 WO PCT/IB1999/000457 patent/WO1999052907A1/fr not_active Ceased
- 1999-03-18 CA CA002327782A patent/CA2327782A1/fr not_active Abandoned
- 1999-03-18 DE DE69910997T patent/DE69910997T2/de not_active Expired - Fee Related
- 1999-03-18 PT PT99945686T patent/PT1070065E/pt unknown
- 1999-04-02 TW TW088105301A patent/TW555758B/zh not_active IP Right Cessation
- 1999-04-05 PE PE1999000270A patent/PE20000413A1/es not_active Application Discontinuation
- 1999-04-07 MA MA25527A patent/MA26619A1/fr unknown
- 1999-04-07 DZ DZ990057A patent/DZ2756A1/fr active
- 1999-04-07 TN TNTNSN99056A patent/TNSN99056A1/fr unknown
- 1999-04-07 MY MYPI99001344A patent/MY133390A/en unknown
- 1999-04-07 AR ARP990101572A patent/AR015751A1/es unknown
- 1999-04-08 ZA ZA9902596A patent/ZA992596B/xx unknown
- 1999-04-08 AP APAP/P/1999/001502A patent/AP1175A/en active
- 1999-04-09 CO CO99021093A patent/CO5080727A1/es unknown
2000
- 2000-09-26 IS IS5641A patent/IS5641A/is unknown
- 2000-10-04 NO NO20005004A patent/NO20005004L/no not_active Application Discontinuation
- 2000-10-06 OA OA1200000273A patent/OA11496A/en unknown
- 2000-11-07 BG BG104915A patent/BG104915A/xx unknown
2003
- 2003-02-11 US US10/364,804 patent/US6887905B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ID26086A (id)	2000-11-23
JP2002511469A (ja)	2002-04-16
TNSN99056A1 (fr)	2005-11-10
ATE248838T1 (de)	2003-09-15
EP1070065B1 (fr)	2003-09-03
JP3496759B2 (ja)	2004-02-16
EA200000910A1 (ru)	2001-04-23
BG104915A (en)	2001-07-31
HUP0102400A3 (en)	2002-10-28
HUP0102400A2 (hu)	2001-11-28
CZ20003684A3 (cs)	2002-03-13
PL343408A1 (en)	2001-08-13
DE69910997T2 (de)	2004-05-19
US6525048B1 (en)	2003-02-25
CO5080727A1 (es)	2001-09-25
YU59400A (sh)	2003-10-31
CN1117092C (zh)	2003-08-06
DK1070065T3 (da)	2003-11-24
SK14782000A3 (sk)	2002-06-04
AP1175A (en)	2003-06-04
HK1035719A1 (en)	2001-12-07
EP1070065A1 (fr)	2001-01-24
IS5641A (is)	2000-09-26
CN1305477A (zh)	2001-07-25
DE69910997D1 (de)	2003-10-09
TW555758B (en)	2003-10-01
MY133390A (en)	2007-11-30
PE20000413A1 (es)	2000-05-25
MA26619A1 (fr)	2004-12-20
AP9901502A0 (en)	1999-06-30
WO1999052907A1 (fr)	1999-10-21
BR9909522A (pt)	2000-12-19
OA11496A (en)	2004-05-14
AR015751A1 (es)	2001-05-16
US6887905B2 (en)	2005-05-03
US20030181458A1 (en)	2003-09-25
PA8469101A1 (es)	2000-09-29
AU749254B2 (en)	2002-06-20
CA2327782A1 (fr)	1999-10-21
NZ507010A (en)	2003-05-30
PT1070065E (pt)	2003-12-31
IL138629A0 (en)	2001-10-31
NO20005004D0 (no)	2000-10-04
ZA992596B (en)	2000-10-08
KR20010042527A (ko)	2001-05-25
AU3268799A (en)	1999-11-01
EA003400B1 (ru)	2003-04-24
ES2204154T3 (es)	2004-04-16
TR200002932T2 (tr)	2001-01-22
HRP20000653A2 (en)	2001-04-30
NO20005004L (no)	2000-11-27
KR100378931B1 (ko)	2003-04-07

Publication	Publication Date	Title
DZ2128A1 (fr)	2002-10-26	Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
CY2537B1 (fr)	2006-06-28	Composés hétérocycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1889A1 (fr)	2002-02-17	Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2891A1 (fr)	2003-12-15	Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2773A1 (fr)	2003-12-01	Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2465A1 (fr)	2003-01-18	Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions les contenant.
DZ2745A1 (fr)	2003-09-08	BicycloÄ2.2.1Üheptanes nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2300A1 (fr)	2002-12-25	Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr)	2002-12-25	Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1957A1 (fr)	2002-02-17	Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2889A1 (fr)	2003-12-15	4-Carboxyamino-2-méthyl-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositionspharmaceutiques les contenant.
DZ2963A1 (fr)	2004-03-15	Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2962A1 (fr)	2004-03-15	Dérivés de 3-azabicycloÄ3,1,0Ühexane nouveaux, procédé pour leur préparation et compositions les contenant.
DZ2303A1 (fr)	2002-12-28	Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2758A1 (fr)	2003-09-15	Dérivés bicycliques d0acide hydroxamique nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2753A1 (fr)	2005-09-15	Hydroxamides d'acides (4-arylsulfonylamino)-tétrahydropyranne-4-carboxyliques) procédé pour leur préparation et compositions les contenant.
MA26659A1 (fr)	2004-12-20	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2395A1 (fr)	2003-06-04	Composés nouveaux a noyau dibenzocycloheptène procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2197A1 (fr)	2002-12-02	Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2729A1 (fr)	2005-03-01	Composés nouveaux inhibiteurs de nhe-1 procédé pour leur préparation et compositions pharmaceutiquesles contenant.
DZ2777A1 (fr)	2003-12-01	Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2718136B1 (fr)	1996-06-21	Composés aromatiques aminés, procédé pour leur obtention et compositions pharmaceutiques les contenant.
DZ3052A1 (fr)	2004-03-27	Composés nouveaux inhibiteurs de métalloprotéases,procédé pour leur préparation et compositions pha rmaceutiques les contenant.
DZ2756A1 (fr)	2003-09-15	Composés azabicycliques substitués nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.